Abstract
Actinobacteria, particularly members of the order Actinomycetales, are one of the most prolific producers of natural products. Wild type strains usually produce very low amounts of natural products, while industry requires significantly higher yields to make production profitable. This justifies the development of extensive research programs aimed at strain improvement. Besides this, recent sequencing efforts revealed that actinobacterial genomes carry dozens of natural product biosynthetic gene clusters, which seem to be silent (or cryptic) under the conditions of traditional fermentation-guided screening procedures. Apparently, production of the natural compounds by actinobacteria is strictly regulated to maximise species competitiveness. Current crisis in the development of new classes of antibiotics against multidrug resistant bacterial pathogens has renewed interest in the different aspects of chemistry and biology of natural products. In this regard, better understanding of the regulatory circuits controlling natural product biosynthesis could greatly advance our abilities of novel antibiotics production. Using model systems, we will discuss what is known about the genetic architecture of regulatory networks that orchestrate natural products biosynthesis in actinobacteria. Then we describe how different elements of these networks could be used to improve strains, discover new molecules and develop new gene expression systems.
Keywords: Actinobacteria, antibiotics, natural products, reporter systems, secondary metabolism, Streptomyces, transcriptional regulators.
The Natural Products Journal
Title:Exploring and Exploiting Gene Networks That Regulate Natural Products Biosynthesis in Actinobacteria
Volume: 3 Issue: 3
Author(s): Bohdam Ostash, I. Ostash, L. Horbal and Victo Fedorenko
Affiliation:
Keywords: Actinobacteria, antibiotics, natural products, reporter systems, secondary metabolism, Streptomyces, transcriptional regulators.
Abstract: Actinobacteria, particularly members of the order Actinomycetales, are one of the most prolific producers of natural products. Wild type strains usually produce very low amounts of natural products, while industry requires significantly higher yields to make production profitable. This justifies the development of extensive research programs aimed at strain improvement. Besides this, recent sequencing efforts revealed that actinobacterial genomes carry dozens of natural product biosynthetic gene clusters, which seem to be silent (or cryptic) under the conditions of traditional fermentation-guided screening procedures. Apparently, production of the natural compounds by actinobacteria is strictly regulated to maximise species competitiveness. Current crisis in the development of new classes of antibiotics against multidrug resistant bacterial pathogens has renewed interest in the different aspects of chemistry and biology of natural products. In this regard, better understanding of the regulatory circuits controlling natural product biosynthesis could greatly advance our abilities of novel antibiotics production. Using model systems, we will discuss what is known about the genetic architecture of regulatory networks that orchestrate natural products biosynthesis in actinobacteria. Then we describe how different elements of these networks could be used to improve strains, discover new molecules and develop new gene expression systems.
Export Options
About this article
Cite this article as:
Ostash Bohdam, Ostash I., Horbal L. and Fedorenko Victo, Exploring and Exploiting Gene Networks That Regulate Natural Products Biosynthesis in Actinobacteria, The Natural Products Journal 2013; 3 (3) . https://dx.doi.org/10.2174/22103155113039990013
DOI https://dx.doi.org/10.2174/22103155113039990013 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Progress Towards the Identification of Inhibitors of Mycobacterial Cell Wall Polysaccharide Biosynthesis
Mini-Reviews in Medicinal Chemistry Nanoemulsion Formulation Enhances Intracellular Activity of Capuramycin Analogues against Mycobacterium Tuberculosis
Drug Delivery Letters 4-Hydroxy-2-pyridone Derivatives and the δ-pyrone Isostere as Novel Agents Against Mycobacterium smegmatis Biofilm Inhibitors
Medicinal Chemistry Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Metal Oxide Nanomaterials in Nanomedicine: Applications in Photodynamic Therapy and Potential Toxicity
Current Topics in Medicinal Chemistry Iodocyclization, Followed by Palladium-Catalyzed Coupling: A Versatile Strategy for Heterocyclic Library Construction
Combinatorial Chemistry & High Throughput Screening Synthesis, Antitrypanosomal and Antimycobacterial Activities of Coumarin N-acylhydrazonic Derivatives
Medicinal Chemistry Current Therapeutic Approaches in Inflammatory Bowel Disease
Current Pharmaceutical Design Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design
Current Drug Targets Functional PLGA NPs for Oral Drug Delivery: Recent Strategies and Developments
Mini-Reviews in Medicinal Chemistry The Diagnosis of Large Airway Pathology and the Role of Rigid Bronchoscopy
Current Respiratory Medicine Reviews New Insights into Invasive Aspergillosis - from the Pathogen to the Disease
Current Pharmaceutical Design The Application of Xpert Mycobacterium tuberculosis/Rifampicin, Quantitative Polymerase Chain Reaction and High Resolution Melting Curve in the Diagnosis of Superficial Lymph Node TB.
Current Pharmaceutical Biotechnology Closing the Gap: An Atomistic Structural and Functional Perspective of S. <i>mansoni</i> Universal Stress G4LZI3 Protein in Complex with Phenolic Compounds
Current Drug Discovery Technologies A Rational Approach to Identify Inhibitors of Mycobacterium tuberculosis Enoyl Acyl Carrier Protein Reductase
Current Pharmaceutical Design Proteomic Analysis of Differentially Expressed Proteins in <i>Mycobacterium Tuberculosis</i>-Infected Macrophages
Current Proteomics Meet the Editorial Board Member
Current Pharmaceutical Biotechnology Targeting Bacterial Metalloenzymes: A New Strategy for the Development of Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry Rip2: A Key Molecule that Regulates both Innate and Acquired Immunity
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Anti-mycobacterial Activity of 22 Iranian Endemic or Rare Plant Extracts Against Multi-drug and Extensively Drug-resistant <i>Mycobacterium tuberculosis</i>
Combinatorial Chemistry & High Throughput Screening